Evaluation of a broadly-based control model of fascioliasis (liver fluke) in central Vietnam

Tran Minh Quy, Heather Yeatman

Abstract


Fascioliasis (liver fluke) has raised significant public health concerns in the 15 regional provinces of Central Vietnam.  However, comprehensive strategies for fascioliasis control are not in place with reliance on chemotherapy as the main control measure. This study implemented a broadly-based control model comprising of five main components: vector control, health education, improvement of local health systems, involvement of concerned bodies, and chemotherapy. Following the intervention, significant reductions in seroprevalence (4.2% vs. 8.8%, p<0.05) was found in the Intervention 1 commune (broadly-based model), but not in the Intervention 2 commune (model comprising of human chemotherapy and animal chemoprevention) or the Control commune (Control commune, human chemotherapy only). Improvements in knowledge and practice of fascioliasis control were found in the intervention communes 1 and 2, although there remained significant differences in the levels of awareness in these two cohorts (80.2% vs. 37.5% respectively, p <0.017). Considerable changes in practices were found in the Intervention 1 commune with all poor practice items reduced significantly in comparison with the baseline level (p<0.017). Findings in this study also supported the effectiveness of the recommended chemotherapy (triclabendazole 250mg, 10mg/kg body weight) for selective treatment of fascioliasis. Having established the effectiveness of the broadly-based control model, it is important to explore the factors that enable, or act to impede, the implementation of a broadly based control model.

Keywords


broadly-based, Central Vietnam, chemotherapy, control, fascioliasis, risk factors, seroprevalence

Full Text:

PDF

References


Mas-Coma S. Epidemiology of fascioliasis in human endemic areas. Journal of Helminthology. 2005a;79(3):207-216.

Trieu NT. Annual workshop reviewing control activities of malaria, parasitic and vector-borne diseases in Central Vietnam in 2010: Institute of Malariology-Parasitology and Entomology, Quy Nhon; 2011:7.

Quy TM, Yeatman H, Flood V, Chuong NC. Prevalence and risks of fascioliasis among adult cohorts in Binh Dinh and Quang Ngai provinces-central Viet Nam. Vietnam Journal of Public Health. 2015;3(1):46-61.

WHO. Report of the WHO Informal Meeting on use of triclabendazole in fascioliasis control. 2007b.

Ortiz P, Scarcella S, Cerna C, et al. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): A clinical trial and an in vivo efficacy test in sheep. Veterinary Parasitology. Jul 2013;195(1-2):118-121.

Nithiuthai S, Anantaphruti MT, Waikagul J, Gajadhar A. Waterborne zoonotic helminthiases. Veterinary parasitology. 2004;126(1):167-193.

Saba R, Korkmaz M. Human fascioliasis. Clinical Microbiology Newsletter. 2005;27(4):27-34.

Nguyen VC, Nguyen VK, Bui VT, Tran MQ. Trial model of fascioliasis control in two communes of Phu Cat district, Binh Dinh province, Vietnam. Journal of Practical Medicine. 2011;796:152-156.

Molyneux DH. Control of human parasitic diseases: Context and overview. Vol 61. SAN DIEGO: ELSEVIER ACADEMIC PRESS INC; 2006:1-45.

GSO. Mean population by gender and urban/rural areas. 2014; http://www.gso.gov.vn/default.aspx?tabid=387&idmid=3&ItemID=15570. Accessed Dec.10, 2014.

Nguyen VQ, Tran TLH, Le PB, Truong THY, Ngo NY. Animal infection of fasioliasis in Binh Dinh province and preventive and control measures Journal of Science and Technology, Department of Science and Technology. 2010.

MOH. Guidelines on diagnosis and treatment of fascioliasis in humans. In: Departmen of Treatment, ed. Hanoi: Ministry of Health; 2006.

Tran VH, Tran TKD. Test kits for diagnoses of parasitological diseases. Journal of Practical Medicine, MOH, Viet Nam. 2004;447:112-116.

Nguyen KL. Study on some characteristics of fascioliasis (Fasciola spp.) and effectiveness of intervention measures in Dai Loc district, Quang Nam province. Ha Noi, Vietnam Military Medical University; 2010.

Nguyen TH. Study on some characteristics and treatment effectiveness of fascioliasis with triclabendazole in Tinh Ky and Nghia Son communes, Quang Ngai province. Ha Noi, National Institute of Malariology-Parasitology and Entomology; 2012.

Nguyen VV, Nguyen MH, Le XH, Nguyen TT. Infections of fascioliasis among the high-risk communities of Quang Nam province. Jounal of Malaria, Parasitic and Entomological control. 2011;3:92-98.

Apt W, Aguilera X, Vega F. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am. J. Trop. Med. Hyg. 1995;52:532-535.

Espinoza JR, Huaman MC, Bargues MD, et al. Evaluation of FAS2-ELISA for the serological detection of Fasciola Hepatica infection in humans American Journal of Tropical Medicine and Hygiene. 2007;76(5):977-982.

Nguyen VV. Study on human fascioliasis and effectiveness of intervention measures in a community of Quang Nam during 2009-2011. Ha Noi: Parasitology Department, National Institute of Malariology-Parasitology and Entomology; 2012.

Winkelhagen AJ, Mank T, de Vries P, Soetekouw R. Apparent Triclabendazole-resistant Human Fasciola hepatica infection, the Netherlands. Emerging Infectious Diseases-CDC. 2012;18(6):1028-1029.

Fairweather I. Triclabendazole progress report, 2005-2009: an advancement of learning? Journal of Helminthology. 2009;83(2):139-150.

Olaechea F, Lovera V, Larroza M, Raffo F, Cabrera R. Resistance of Fasciola hepatica against triclabendazole in cattle in Patagonia (Argentina). Veterinary Parasitology. 2011;178(3-4):364-366.

Nguyen TGT. Zoonotic fascioliasis in Vietnam: molecular identification and geographical distribution: Department of Virology, Parasitology and Immunology-Faculty of Veterinary Medicine, Ghent University, Ghent Univerisity-Belgium; 2012.

Nguyen VC, Trieu NT, Nguyen VK, Bui VT. Study on some epidemiological characteristics of fasioliasis in some study sites of Central Vietnam. Monograph of Scientific research studies. 2007:410-416.

Curtale F, Mas-Coma S, El Wahab Hassanein YA, Barduagni P, Pezzotti P, Savioli L. Clinical signs and household characteristics associated with human fascioliasis among rural population in Egypt: A case-control study. Parassitologia. 2003;45(1):5-11.

Nguyen KL, Do NA, Nguyen NS. Identification of fascioliasis infection in cattle and risk factors of human transmission in Dai Loc district-Quang Nam province. Jounal of Malaria, Parasitic and Entomological control-National Institute of Malariology-Parasitology and Entomology. 2011;3:76-82.

Dang TCT, Nguyen XT, Nguyen MH, Trieu NT. Epidemiological charateristics and control measures of fascioliasis in Vietnam Hanoi: Ministry of Health;2011.

Rojas L, Vazquez A, Domenech I, Robertson LJ. Fascioliasis: can Cuba conquer this emerging parasitosis? Trends in parasitology. 2010;26(1):26-34.

Chen J-X, Guo Y-H, Chen M-X, et al. An Outbreak of Human Fascioliasis gigantica in Southwest China. . PLoS ONE. 2013;8(8).

Keiser J, Utzinger I. Food-borne trematodiasis. Clinical Miriobiological Review. 2009;22:466-483.

Agnamey P, Fortes-Lopes E, Raccurt CP, Boncy J, Totet A. Cross-sectional serological survey of human fascioliasis in haiti. Journal of parasitology research. 2012;2012(Journal Article):751951-751953.

Mas-Coma S, Esteban JG, Bargues MD. Epidemiology of human fascioliasis: a review and proposed new classification. Bulletin of the World Health Organization. 1999a;77:340-346.